Accelsiors CRO announce successful completion of a Phase III study in oncology.
“Accelsiors CRO is happy to announce the successful completion of a Phase III Clinical Trial in oncology, on a biosimilar compound. Thanks to the Team who worked on this complex study, we were able to wrap up all of our activities, starting from a very challenging set-up phase all the way to the data base lock in less than 2 years,” said Mihaly Juhasz, Chief Executive Officer of Accelsiors CRO.
“This was one of the most challenging projects Accelsiors CRO had worked on,” said Desislava Simeonova MD, Head of Clinical Operations at Accelsiors CRO. “This is one more reason for us to be happy with the high quality of work our Team was able to demonstrate during the whole course of the study. We had 10 countries on board, a high number of sites per country and some challenging subject eligibility criteria which had to be followed. Despite of all of these challenges that we encountered along the way, Accelsiors CRO has shown a significant level of experience and expertise in this field, allowing us to successfully make our way towards achieving the mission of this project. I would like to thank the whole team once again for their dedication and for the quality of work shown on this project, and I look forward to working with all of them again on Accelsiors’ new projects in oncology.”
Accelsiors CRO & Consultancy Services Ltd. is a midsized full service European Contract Research Organization, a provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. By combining our unique experience and expertise as well as our comprehensive capabilities across all areas of clinical drug development, we assist our clients to become successful drug developers. We have the operational flexibility to provide development services that perfectly match the demands of each of our clients, as part of an integrated “full service” solution. We specialize in the strategic planning, development, management and analysis of programs that support Clinical Development – from Phase I to marketing authorization and beyond.
Accelsiors is a synonym for Acceleration, Excellence & Achievements in clinical drug development. Every effort is made within Accelsiors to truly understand, accurately determine, clearly and consistently communicate and continuously satisfy the requirements of our clients in a manner which is efficient and effective to them whilst providing Accelsiors with the opportunity to grow and excel.
For further information please contact Accelsiors Communication Manager, Mr. Ferenc Erdos at F.Erdos@accelsiors.com.